ERBB2 and breast carcinoma: We next assessed whether the inhibitory effect of lapatinib on ERRα expression also occurs in vivo using both a mouse model of human HER2-driven breast cancer (MMTV-NIC)37 and HER2-positive patient-derived xenografts (PDXs) propagated in NOG mice.